HealthDay News — The European Association for the Study of Obesity (EASO) framework may offer a more sensitive measure of obesity than traditional body mass index (BMI), according to a study published ...

Rhythm's bivamelagon cut BMI and hunger scores in Phase 2 trial for hypothalamic obesity, prompting plans to discuss Phase 3 ...

About 1 in 5 classified as overweight based on BMI alone considered to have obesity according to European society definition.

Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...

Zuellig Pharma, a leading healthcare solutions provider in Asia, is organizing the "Obesity is a Disease" seminar as part of ...

Obesity and heart failure often go together, making treatment more complicated. Now, health experts have released new ...

Rhythm Pharmaceuticals' experimental drug helped patients with a rare form of obesity caused by brain damage cut weight in a small study, the drugmaker said on Monday, sending its shares 24% higher in ...

To improve access to care, many professional organizations have advocated for classifying obesity as a disease. However, the ...

Obesity in itself is not a contraindication to radical prostatectomy, but it remains a risk factor for poor overall survival. Although obesity increases the technical complexity of radical ...

Bivamelagon achieved BMI reductions in patients with acquired hypothalamic obesity of -9.3% and -7.7% in 600mg and 400mg cohorts, respectively, at 14 weeks -- -- Post-hoc analysis showed BMI reduction ...

The urgent directive follows alarming findings by Lancet, the British medical journal, that projected a surge in overweight ...

Understanding the link between obesity, fatty liver disease and kidney stones provides a new perspective on prevention and ...